Skip to main content
Sandra D'Angelo, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

SandraPD'AngeloMD

Oncology New York, NY

Hematologic Oncology, Sarcoma

Associate Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. D'Angelo

Dr. Sandra D'Angelo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 13 years. Dr. D'Angelo accepts several types of health insurance, listed below. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 88 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 70 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2004 - 2007
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2005 - 2025
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Pilot study of NKTR214 and nivolumab in patients with sarcomas. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Desmoid Tumors Biology: Exploiting Estrogen and Notch Signaling 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Pilot study of NY-ESO-1c259 T cells in advanced myxoid/round cell liposarcoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • T-cell Therapy Shows Promise in Rare Sarcomas
    T-cell Therapy Shows Promise in Rare SarcomasNovember 12th, 2021
  • Immunotherapy Jumps Ahead of Chemotherapy in Advanced Merkel Cell Carcinoma
    Immunotherapy Jumps Ahead of Chemotherapy in Advanced Merkel Cell CarcinomaApril 5th, 2019

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Humana ChoiceCare Network PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment